Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Ala-Fossi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Drugs & Aging|October 29, 1997
Toremifene in postmenopausal breast cancer. Efficacy, safety and costJ U Mäenpää, S L Ala-Fossi
Maturitas|August 12, 1998
Ovarian testosterone secretion during perimenopauseS L Ala-Fossi, J Mäenpää, R Aine, et al.
European Journal of Gynaecological Oncology|June 8, 2000
Is potential to produce inhibins related to prognosis in ovarian granulosa cell tumors?S L Ala-Fossi, R Aine, R Punnonen, et al.
European Journal of Endocrinology|April 8, 2000
Inhibin A, B and pro-alphaC in serum and peritoneal fluid in postmenopausal patients with ovarian tumorsS L Ala-Fossi, J Mäenpää, M Bläuer, et al.
Maturitas|January 9, 1999
Inhibin A and B in peri- and postmenopauseS L Ala-Fossi, J Mäenpää, M Bläuer, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 19, 1999
In the dose range of 0.5-2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnanciesM Vainio, J Mäenpää, A Riutta, et al.
Anticancer Research|January 11, 2000
Ovarian cancer and gonadotropins in vitro: new evidence in favor of independenceS L Ala-Fossi, S Grenman, F P Zhang, et al.
Gynecologic Oncology|September 23, 1997
Prognostic significance of p53 expression in ovarian granulosa cell tumorsS L Ala-Fossi, J Mäenpää, R Aine, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Drugs & Aging|October 29, 1997
Toremifene in postmenopausal breast cancer. Efficacy, safety and costJ U Mäenpää, S L Ala-Fossi
Maturitas|August 12, 1998
Ovarian testosterone secretion during perimenopauseS L Ala-Fossi, J Mäenpää, R Aine, et al.
European Journal of Gynaecological Oncology|June 8, 2000
Is potential to produce inhibins related to prognosis in ovarian granulosa cell tumors?S L Ala-Fossi, R Aine, R Punnonen, et al.
European Journal of Endocrinology|April 8, 2000
Inhibin A, B and pro-alphaC in serum and peritoneal fluid in postmenopausal patients with ovarian tumorsS L Ala-Fossi, J Mäenpää, M Bläuer, et al.
Maturitas|January 9, 1999
Inhibin A and B in peri- and postmenopauseS L Ala-Fossi, J Mäenpää, M Bläuer, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 19, 1999
In the dose range of 0.5-2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnanciesM Vainio, J Mäenpää, A Riutta, et al.
Anticancer Research|January 11, 2000
Ovarian cancer and gonadotropins in vitro: new evidence in favor of independenceS L Ala-Fossi, S Grenman, F P Zhang, et al.
Gynecologic Oncology|September 23, 1997
Prognostic significance of p53 expression in ovarian granulosa cell tumorsS L Ala-Fossi, J Mäenpää, R Aine, et al.
Pageof 1